-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Terns Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2020 to Q2 2024.
- Terns Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$25.5M, a 20.7% decline year-over-year.
- Terns Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$108M, a 36.2% decline year-over-year.
- Terns Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$103M, a 65.3% decline from 2022.
- Terns Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$62M, a 24.4% decline from 2021.
- Terns Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$49.9M, a 34.7% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)